Elite paid Mikah $1.2M for #1 drug with two million dollar sales, and Nostrum paid Elite $1.2M for #4 IR opioids with annual sales worth hundreds of millions of dollars.
I'd be very interested to hear from any investors who think this sounds legit. If this seems like an above-board, arm's length, righteous business deal, then please reply with further explanation. For me, I can only see the APPEARANCE OF IMPROPRIETY.